Maintenance of Efficacy.

This study has been withdrawn prior to enrollment.

(This study has been cancelled as the esreboxetine development program is being discontinued. Safety and efficacy were not factors.)

Sponsor:

Information provided by:

Pfizer

ClinicalTrials.gov Identifier:

NCT00796601

First received: November 20, 2008

Last updated: March 17, 2009

Last verified: March 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	November 2010
Estimated Primary Completion Date:	May 2010 (Final data collection date for primary outcome measure)